FDAnews Device Daily Bulletin
Medical Devices / Commercial Operations

India Places Coronary Stents on Drug List

July 27, 2016

It’s ironic that at the same time India is separating out medical device regulations from pharmaceutical regulations for the first time, it will now place coronary stents on its national drug list.

The move will mean the stents will likely also fall under price controls.

After numerous meetings with stent manufacturers, cardiologists and NGOs, a government committee created in 2011 concluded that the stents are essential, and thus should appear on the National List of Essential Medicines. — Tamra Sami

View today's stories